Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs336592 | chr3:161077186 | T/C | 1.11E-16 | 173 | 25.87 | 19.85 | 1.63 | KM Plot |
PCPG | rs33934962 | chr8:126141595 | AAC/A | 8.16E-9 | 175 | 25.28 | 28.3 | 3.67 | KM Plot |
PCPG | rs33972312 | chr2:24308872 | A/G | 0.000118 | 177 | 25.28 | 26.57 | 17.43 | KM Plot |
PCPG | rs33983199 | chr14:74627713 | A/T | 1.79E-5 | 178 | 10.43 | 27.27 | 25.4 | KM Plot |
PCPG | rs33998519 | chr19:15412007 | T/C | 6.91E-7 | 174 | 25.47 | 21.12 | 10.68 | KM Plot |
PCPG | rs34002193 | chr12:31786920 | C/CA | 0.000291 | 178 | 24.6 | 27.95 | 16.83 | KM Plot |
PCPG | rs34003621 | chr3:80557350 | C/CA | 2.79E-5 | 177 | 19.53 | 24.77 | 27.2 | KM Plot |
PCPG | rs34015581 | chr16:71508229 | T/A | 0 | 176 | 25.17 | 25.27 | 3.17 | KM Plot |
PCPG | rs34018329 | chr2:24310865 | G/A | 0.00011 | 178 | 25.28 | 26.92 | 17.43 | KM Plot |
PCPG | rs34026405 | chr14:74643733 | C/T | 0.000221 | 176 | 25.28 | 26.57 | 10.57 | KM Plot |
PCPG | rs34027780 | chr5:179478891 | C/A | 0.000238 | 176 | 24.17 | 29.95 | 14.83 | KM Plot |
PCPG | rs34031668 | chr2:242533379 | T/C | 4.16E-5 | 177 | 25.87 | 27.27 | 20.2 | KM Plot |
PCPG | rs34033205 | chr16:89922959 | G/T | 0.000185 | 172 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs34040967 | chr5:171531685 | CGCT/C | 0.000114 | 177 | 25.87 | 22.3 | 17.12 | KM Plot |
PCPG | rs34058768 | chr2:239110446 | GAA/G | 2.92E-5 | 170 | 29.43 | 18.2 | 13.22 | KM Plot |